Technology is designed to help us live and work smarter. That is exactly what P21’s Community and Enterprise applications were designed to do – to help study teams collect, transform,…
Keep the pain out of compliance Call in the experts! Get in touch with our Transparency and Disclosure team We’re the leading technology and services provider in clinical trial transparency…
Welcome to the forefront of drug development innovation! The drug development landscape is rapidly evolving, and we’re excited to introduce you to the concept of the “parallel virtual universe.” This…
Updates advance the mission of the FDA’s new Quantitative Medicine Center of Excellence, which seeks to leverage biosimulation for therapeutic medical product development and inform regulatory decision-making. RADNOR, PA —…
Discover how Certara’s Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing efficiency and ensuring regulatory readiness.
Learn more about how our pharmacometricians can help you de-risk your drug development program. Transcript: Hello, and welcome to Certara Talks. My name is doctor Suzanne Minton, and I’m a…
The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD modeling and simulation software innovations.
Drs. Gabrielsson and Wendt will continue to co-present a new case study about analyzing acute and repeated dosing of a monoclonal antibody (mAb from literature data), and then extend the…
Radnor, PA — 2024年5月29日 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference. Company…
© 2025 Certara. All Rights Reserved. | 個人情報保護
